MENU
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Halozyme Therapeutics (HALO) Ownership - Who owns Halozyme Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.22B
P/E Ratio
22.08
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
74.60
Revenue/Share
6.67 USD as % of share price
Fundamentals
HALO
Capitalization
7.22B
P/E Ratio
22.08
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
74.60
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.67%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
24.94
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
127M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
65.639
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com